Predictors of early mortality and effectiveness of antiretroviral therapy in TB-HIV patients from Brazil.
Fernanda O DemittoCarolina A S SchmaltzFlávia M Sant'AnnaMaría Belen ArriagaBruno Bezerril AndradeValeria C RollaPublished in: PloS one (2019)
Risk factors for mortality and ARV failure were different for ARV-naïve and ARV-experienced patients. The latter patient group should be targeted for trials with less toxic and rifampicin-compatible drugs to improve TB-HIV treatment outcomes and prevent death.
Keyphrases
- antiretroviral therapy
- hiv infected
- end stage renal disease
- human immunodeficiency virus
- hiv positive
- ejection fraction
- mycobacterium tuberculosis
- newly diagnosed
- hiv aids
- hepatitis c virus
- peritoneal dialysis
- systematic review
- cardiovascular events
- risk factors
- cardiovascular disease
- type diabetes
- hiv infected patients
- coronary artery disease
- patient reported
- drug induced